The main form of treatment for type two diabetes is with the prescription of pills or the injection of insulin [9]. In order to know how much treatment is necessary, monitoring the blood glucose levels is a good indicator of the dosage required as the blood glucose levels can fluctuate.

While there are two commonly used solutions to track the blood glucose levels, the most traditional method of the two is with the use of glucometers (also known as the finger-prick method). These devices allow diabetics to measure blood glucose levels from the sample of blood collected—usually from pricking a diabetic’s finger with a lancet. This, in turn, allows the diabetic to predict how much insulin is needed for injection [10]. There are limitations to glucometers, however. Type 2 diabetics may have to test multiple times a day and even plan according to when they eat as that can affect blood glucose levels [11]. Glucometers are not efficient in that the patient will need to purchase a lot of accessory equipment, which can add up to a large sum of payment for treatment each month. Moreover, all these accessories make room for errors [12].

The other form of solution for type two diabetes is the widely accepted continuous glucose monitoring (CGM) paired with an insulin pump. As the name implies, the CGM tracks the diabetic’s blood glucose levels continuously throughout the day to get the most accurate reading. Essentially, the parts of the CGM is simple: there is the sensor that is inserted into the fat portion of the skin that collects data and the transmitter that sends data wirelessly to apps on various platforms or to the insulin pump delivery system [13]. CGMs are highly popular as diabetics have more freedom in completing and enjoying everyday tasks; however, there are still some limitations that we will be discussing in our design criteria to try to mitigate some of these flaws in the current treatments.